ARCA biopharma Inc (ABIO)
3.45
+0.05
(+1.47%)
USD |
NASDAQ |
Apr 22, 16:00
3.47
+0.02
(+0.58%)
After-Hours: 20:00
ARCA biopharma Net Income (Quarterly): -1.089M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.089M |
| September 30, 2023 | -1.424M |
| June 30, 2023 | -1.48M |
| March 31, 2023 | -1.346M |
| December 31, 2022 | -1.174M |
| September 30, 2022 | -2.333M |
| June 30, 2022 | -3.147M |
| March 31, 2022 | -3.272M |
| December 31, 2021 | -5.676M |
| September 30, 2021 | -4.712M |
| June 30, 2021 | -4.834M |
| March 31, 2021 | -4.10M |
| December 31, 2020 | -5.125M |
| September 30, 2020 | -1.991M |
| June 30, 2020 | -1.302M |
| March 31, 2020 | -1.32M |
| December 31, 2019 | -1.226M |
| September 30, 2019 | -1.156M |
| June 30, 2019 | -1.436M |
| March 31, 2019 | -1.664M |
| December 31, 2018 | -1.489M |
| September 30, 2018 | -1.593M |
| June 30, 2018 | -2.116M |
| March 31, 2018 | -2.733M |
| December 31, 2017 | -4.196M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.431M |
| June 30, 2017 | -5.518M |
| March 31, 2017 | -4.328M |
| December 31, 2016 | -4.257M |
| September 30, 2016 | -4.678M |
| June 30, 2016 | -3.887M |
| March 31, 2016 | -3.641M |
| December 31, 2015 | -3.168M |
| September 30, 2015 | -2.814M |
| June 30, 2015 | -2.719M |
| March 31, 2015 | -2.744M |
| December 31, 2014 | -2.611M |
| September 30, 2014 | -2.284M |
| June 30, 2014 | -2.405M |
| March 31, 2014 | -2.389M |
| December 31, 2013 | -2.946M |
| September 30, 2013 | -1.723M |
| June 30, 2013 | -1.199M |
| March 31, 2013 | -1.071M |
| December 31, 2012 | -0.84M |
| September 30, 2012 | -0.927M |
| June 30, 2012 | -1.146M |
| March 31, 2012 | -1.407M |
| December 31, 2011 | -1.63M |
| September 30, 2011 | -1.822M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.676M
Minimum
Dec 2021
-1.089M
Maximum
Dec 2023
-2.534M
Average
-1.48M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Shockwave Medical Inc | 44.30M |
| Asensus Surgical Inc | -17.24M |
| Glaukos Corp | -36.78M |
| Helius Medical Technologies Inc | -1.045M |
| Perspective Therapeutics Inc | -24.68M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.59M |
| EPS Diluted (Quarterly) | -0.08 |
| Enterprise Value | 12.60M |
| Earnings Yield | -10.72% |